Level Four Advisory Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-9,064
| Closed | -$1.67M | – | 676 |
|
|
2021
Q2 | $1.67M | Buy |
9,064
+585
| +7% | +$107K | 0.12% | 197 |
|
|
2021
Q1 | $1.3M | Buy |
8,479
+986
| +13% | +$151K | 0.1% | 220 |
|
|
2020
Q4 | $1.17M | Sell |
7,493
-289
| -4% | -$45.2K | 0.09% | 215 |
|
|
2020
Q3 | $890K | Sell |
7,782
-231
| -3% | -$26.4K | 0.07% | 261 |
|
|
2020
Q2 | $894K | Sell |
8,013
-444
| -5% | -$49.5K | 0.07% | 269 |
|
|
2020
Q1 | $762K | Buy |
8,457
+877
| +12% | +$79K | 0.09% | 247 |
|
|
2019
Q4 | $3.93M | Buy |
7,580
+1,635
| +28% | +$847K | 0.16% | 162 |
|
|
2019
Q3 | $582K | Buy |
5,945
+417
| +8% | +$40.8K | 0.06% | 299 |
|
|
2019
Q2 | $723K | Buy |
5,528
+41
| +0.7% | +$5.36K | 0.07% | 256 |
|
|
2019
Q1 | $743K | Buy |
5,487
+96
| +2% | +$13K | 0.08% | 240 |
|
|
2018
Q4 | $525K | Sell |
5,391
-13
| -0.2% | -$1.27K | 0.07% | 284 |
|
|
2018
Q3 | $751K | Sell |
5,404
-1,086
| -17% | -$151K | 0.08% | 254 |
|
|
2018
Q2 | $806K | Sell |
6,490
-455
| -7% | -$56.5K | 0.06% | 281 |
|
|
2018
Q1 | $774K | Buy |
6,945
+432
| +7% | +$48.1K | 0.06% | 277 |
|
|
2017
Q4 | $779K | Sell |
6,513
-77
| -1% | -$9.21K | 0.06% | 285 |
|
|
2017
Q3 | $925K | Buy |
6,590
+2,832
| +75% | +$398K | 0.08% | 233 |
|
|
2017
Q2 | $437K | Sell |
3,758
-2,784
| -43% | -$324K | 0.07% | 283 |
|
|
2017
Q1 | $774K | Buy |
6,542
+417
| +7% | +$49.3K | 0.08% | 250 |
|
|
2016
Q4 | $749K | Buy |
+6,125
| New | +$749K | 0.1% | 208 |
|